How to Buy nureca Shares on Fincept?
You can buy Nureca Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Nureca Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Nureca, including updates on board meetings and corporate actions.
Nureca Limited - https://www.nureca.com
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, connected products, glucose meters, and thermometers; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, massagers, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, blood pressure monitors, glucometer, fitness trackers, and smart weighing scales. The company offers its products under the Dr Trust, Dr Physio, and Trumom brands. It markets its products through e-commerce platforms, distributors, retailers, and its websites. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.
Nureca Limited Share Price Today
303.55
OPEN
303.55
HIGH
288.40
LOW
288.40
CLOSE
36 K
VOLUME
281 Cr
Market Cap
19515
Average Volume
Healthcare
Sector
NSI
Exchange
Nureca Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: NURECA Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Nureca Limited |
NURECA |
INE0DSF01015 |
Annual General Meeting |
11 Jul 2024 |
10 |
N/A |
Nureca Limited |
NURECA |
INE0DSF01015 |
Annual General Meeting |
13 Jul 2023 |
10 |
N/A |
Nureca Limited |
NURECA |
INE0DSF01015 |
Annual General Meeting |
01 Sep 2022 |
10 |
N/A |
Nureca Limited |
NURECA |
INE0DSF01015 |
Annual General Meeting |
13 Jul 2022 |
10 |
N/A |
Nureca Limited |
NURECA |
INE0DSF01015 |
Interim Dividend - Rs 3 Per Share |
24 Feb 2022 |
10 |
N/A |
NSE: NURECA Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
NURECA |
30 Dec 2024, 12:30:30 |
Updates |
N/A |
NURECA |
26 Dec 2024, 12:31:40 |
Trading Window |
N/A |
NURECA |
26 Dec 2024, 12:30:38 |
Trading Window-XBRL |
N/A |
NURECA |
18 Dec 2024, 18:54:56 |
Acquisition |
N/A |
NURECA |
18 Dec 2024, 18:39:00 |
Acquisition-XBRL |
N/A |
NSE: NURECA Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Nureca Limited |
NURECA |
10 Jan 2025, 10:54:00 |
10 Jan 2025, 10:55:00 |
|
Nureca Limited |
NURECA |
10 Oct 2024, 12:15:00 |
10 Oct 2024, 12:15:00 |
|
Nureca Limited |
NURECA |
08 Nov 2024, 16:56:00 |
08 Nov 2024, 16:56:00 |
|
Nureca Limited |
NURECA |
12 Jul 2024, 17:24:00 |
12 Jul 2024, 17:24:00 |
|
Nureca Limited |
NURECA |
17 Apr 2024, 16:46:00 |
17 Apr 2024, 17:15:00 |
NSE: NURECA Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson Related To Promoters,Executive Director-MD |
02 Jan 1986 |
11 Feb 2017 |
00136037 |
SAURABH GOYAL |
Active |
Independent Director |
19 Dec 1958 |
21 Oct 2020 |
02449088 |
VIJAY KUMAR SHARMA |
Active |
Independent Director |
13 Oct 1985 |
21 Oct 2020 |
07822158 |
CHARU SINGH |
Active |
Independent Director |
06 Apr 1984 |
29 Oct 2020 |
08941249 |
RUCHITA AGARWAL |
Active |
Independent Director |
13 Apr 1986 |
29 Mar 2021 |
00509297 |
VIKRAM CHAUDHERY |
Active |
NSE: NURECA Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
NURECA LIMITED has informed the Exchange about Board Meeting to be held on 24-Oct-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. |
NURECA |
N/A |
INE0DSF01015 |
Nureca Limited |
17 Oct 2024, 16:22:15 |
Financial Results/Other business matters |
NURECA |
N/A |
INE0DSF01015 |
Nureca Limited |
29 Jul 2024, 15:03:19 |
Financial Results/Other business matters |
NURECA |
N/A |
INE0DSF01015 |
Nureca Limited |
08 May 2024, 18:02:46 |
Financial Results/Other business matters |
NURECA |
N/A |
INE0DSF01015 |
Nureca Limited |
31 Jan 2024, 17:18:10 |
NURECA LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . |
NURECA |
N/A |
INE0DSF01015 |
Nureca Limited |
28 Oct 2023, 14:58:03 |
NSE: NURECA Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results/Other business matters |
NURECA |
- |
INE0DSF01015 |
Nureca Limited |
17 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Financial Results/Other business matters |
NURECA |
- |
INE0DSF01015 |
Nureca Limited |
29 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Financial Results/Other business matters |
NURECA |
- |
INE0DSF01015 |
Nureca Limited |
08 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
Financial Results/Other business matters |
NURECA |
- |
INE0DSF01015 |
Nureca Limited |
31 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Financial Results/Other business matters |
NURECA |
- |
INE0DSF01015 |
Nureca Limited |
28 Oct 2023, 00:00:00 |
To consider and approve the Unaudited financial results (Standalone and Consolidated) for the second quarter and half year ended September 30, 2023. |
NSE: NURECA Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Finished Goods | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 10,000,175.00 | 10,000,175.00 | 60,000.00 | 53,050,000.00 | 1,921,690,000.00 | 1,965,490,000.00 | 1,773,290,000.00 | 1,921,690,000.00 | 30,640,000.00 | 1,943,080,000.00 | 1,952,750,000.00 | 1,943,080,000.00 | 1,943,080,000.00 | 1,843,080,000.00 | 0.00 | 0.00 | 100,000,000.00 | 100,000,000.00 | 206,470,000.00 | 41,520,000.00 | 0.00 | 0.00 | 30,490,000.00 | 20,820,000.00 | 9,670,000.00 | 11,030,000.00 | 164,950,000.00 | 30,110,000.00 | 22,560,000.00 | 9,820,000.00 | 12,740,000.00 | 0.00 | 1,980,000.00 | 109,700,000.00 | 0.00 | 0.00 | 15,140,000.00 | 94,560,000.00 | 2,149,550,000.00 | 211,310,000.00 | 0.00 | 48,500,000.00 | 63,350,000.00 | 63,350,000.00 | 21,390,000.00 | 0.00 | 72,100,000.00 | 0.00 | 72,100,000.00 | 0.00 | 72,100,000.00 | 0.00 | 0.00 | 0.00 | 1,938,240,000.00 | 129,670,000.00 | 0.00 | 0.00 | 276,500,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100,170,000.00 | 0.00 | 0.00 | 1,431,900,000.00 | 1,409,550,000.00 | 22,350,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 10,000,175.00 | 10,000,175.00 | 0.00 | 25,160,000.00 | 1,908,130,000.00 | 1,935,940,000.00 | 1,833,190,000.00 | 1,908,130,000.00 | 20,320,000.00 | 1,931,100,000.00 | 1,934,360,000.00 | 1,931,100,000.00 | 1,931,100,000.00 | 1,831,110,000.00 | 856,380,000.00 | 987,790,000.00 | 100,000,000.00 | 100,000,000.00 | 120,550,000.00 | 27,820,000.00 | 10,000.00 | 0.00 | 18,050,000.00 | 14,790,000.00 | 3,260,000.00 | 9,760,000.00 | 92,730,000.00 | 8,800,000.00 | 7,110,000.00 | 5,530,000.00 | 1,580,000.00 | 0.00 | 1,680,000.00 | 70,120,000.00 | 9,900,000.00 | 120,000.00 | 8,360,000.00 | 51,740,000.00 | 2,051,650,000.00 | 125,730,000.00 | 10,000.00 | 49,020,000.00 | 2,920,000.00 | 2,920,000.00 | 22,970,000.00 | 22,970,000.00 | 50,810,000.00 | -36,070,000.00 | 86,880,000.00 | 2,700,000.00 | 48,120,000.00 | 47,160,000.00 | 37,020,000.00 | 0.00 | 1,925,920,000.00 | 2,460,000.00 | 299,260,000.00 | 131,090,000.00 | 308,510,000.00 | 284,730,000.00 | 23,780,000.00 | 28,900,000.00 | 0.00 | 16,150,000.00 | 0.00 | 16,150,000.00 | 1,139,550,000.00 | 998,930,000.00 | 140,620,000.00 | 127,500,000.00 | 13,120,000.00 |
| 2024-03-31T00:00:00 | annual | 10,000,175.00 | 10,000,175.00 | 0.00 | 25,160,000.00 | 1,908,130,000.00 | 1,935,940,000.00 | 1,833,190,000.00 | 1,908,130,000.00 | 20,320,000.00 | 1,931,100,000.00 | 1,934,360,000.00 | 1,931,100,000.00 | 1,931,100,000.00 | 1,831,110,000.00 | 856,380,000.00 | 987,790,000.00 | 100,000,000.00 | 100,000,000.00 | 120,550,000.00 | 27,820,000.00 | 10,000.00 | 0.00 | 18,050,000.00 | 14,790,000.00 | 3,260,000.00 | 9,760,000.00 | 92,730,000.00 | 8,800,000.00 | 7,110,000.00 | 5,530,000.00 | 1,580,000.00 | 0.00 | 1,680,000.00 | 70,120,000.00 | 9,900,000.00 | 120,000.00 | 8,360,000.00 | 51,740,000.00 | 2,051,650,000.00 | 125,730,000.00 | 10,000.00 | 49,020,000.00 | 2,920,000.00 | 2,920,000.00 | 22,970,000.00 | 22,970,000.00 | 50,810,000.00 | -36,070,000.00 | 86,880,000.00 | 2,700,000.00 | 48,120,000.00 | 47,160,000.00 | 37,020,000.00 | 0.00 | 1,925,920,000.00 | 2,460,000.00 | 299,260,000.00 | 131,090,000.00 | 308,510,000.00 | 284,730,000.00 | 23,780,000.00 | 28,900,000.00 | 0.00 | 16,150,000.00 | 0.00 | 16,150,000.00 | 1,139,550,000.00 | 998,930,000.00 | 140,620,000.00 | 127,500,000.00 | 13,120,000.00 |
| 2023-09-30T00:00:00 | quarterly | 10,000,175.00 | 10,000,175.00 | 0.00 | 27,590,000.00 | 1,945,840,000.00 | 1,971,220,000.00 | 1,858,670,000.00 | 1,945,840,000.00 | 26,760,000.00 | 1,970,390,000.00 | 1,970,390,000.00 | 1,970,390,000.00 | 1,970,390,000.00 | 1,870,390,000.00 | 0.00 | 0.00 | 100,000,000.00 | 100,000,000.00 | 119,530,000.00 | 26,150,000.00 | 0.00 | 0.00 | 16,850,000.00 | 16,850,000.00 | 0.00 | 9,300,000.00 | 93,380,000.00 | 20,180,000.00 | 10,740,000.00 | 9,910,000.00 | 830,000.00 | 0.00 | 2,960,000.00 | 59,110,000.00 | 0.00 | 0.00 | 3,840,000.00 | 55,270,000.00 | 2,089,920,000.00 | 137,870,000.00 | 0.00 | 21,930,000.00 | 24,740,000.00 | 24,740,000.00 | 24,550,000.00 | 0.00 | 51,400,000.00 | 0.00 | 51,400,000.00 | 0.00 | 51,400,000.00 | 0.00 | 0.00 | 0.00 | 1,952,050,000.00 | 144,460,000.00 | 0.00 | 0.00 | 403,730,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 56,320,000.00 | 0.00 | 0.00 | 1,347,540,000.00 | 1,331,790,000.00 | 15,750,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 10,000,175.00 | 10,000,175.00 | 0.00 | 33,270,000.00 | 1,922,680,000.00 | 1,949,630,000.00 | 1,776,800,000.00 | 1,922,680,000.00 | 32,450,000.00 | 1,948,810,000.00 | 1,948,810,000.00 | 1,948,810,000.00 | 1,948,810,000.00 | 1,848,820,000.00 | 874,060,000.00 | 987,790,000.00 | 100,000,000.00 | 100,000,000.00 | 116,980,000.00 | 28,150,000.00 | 0.00 | 0.00 | 20,270,000.00 | 20,270,000.00 | 0.00 | 7,880,000.00 | 88,830,000.00 | 10,460,000.00 | 13,000,000.00 | 12,180,000.00 | 820,000.00 | 0.00 | 2,300,000.00 | 59,580,000.00 | 8,870,000.00 | 130,000.00 | 680,000.00 | 49,900,000.00 | 2,065,790,000.00 | 200,160,000.00 | -20,000.00 | 27,290,000.00 | 75,250,000.00 | 75,250,000.00 | 26,130,000.00 | 26,130,000.00 | 60,420,000.00 | -27,750,000.00 | 88,170,000.00 | 0.00 | 7,960,000.00 | 39,020,000.00 | 49,150,000.00 | 0.00 | 1,865,630,000.00 | 3,350,000.00 | 299,260,000.00 | 123,770,000.00 | 344,770,000.00 | 327,690,000.00 | 17,080,000.00 | 21,590,000.00 | 9,320,000.00 | 42,950,000.00 | -250,000.00 | 43,200,000.00 | 1,020,620,000.00 | 1,015,580,000.00 | 5,040,000.00 | 0.00 | 5,040,000.00 |
| 2023-03-31T00:00:00 | annual | 10,000,175.00 | 10,000,175.00 | 0.00 | 33,270,000.00 | 1,922,680,000.00 | 1,949,630,000.00 | 1,776,800,000.00 | 1,922,680,000.00 | 32,450,000.00 | 1,948,810,000.00 | 1,948,810,000.00 | 1,948,810,000.00 | 1,948,810,000.00 | 1,848,820,000.00 | 874,060,000.00 | 987,790,000.00 | 100,000,000.00 | 100,000,000.00 | 116,980,000.00 | 28,150,000.00 | 0.00 | 0.00 | 20,270,000.00 | 20,270,000.00 | 0.00 | 7,880,000.00 | 88,830,000.00 | 10,460,000.00 | 13,000,000.00 | 12,180,000.00 | 820,000.00 | 0.00 | 2,300,000.00 | 59,580,000.00 | 8,870,000.00 | 130,000.00 | 680,000.00 | 49,900,000.00 | 2,065,790,000.00 | 200,160,000.00 | -20,000.00 | 27,290,000.00 | 75,250,000.00 | 75,250,000.00 | 26,130,000.00 | 26,130,000.00 | 60,420,000.00 | -27,750,000.00 | 88,170,000.00 | 0.00 | 7,960,000.00 | 39,020,000.00 | 49,150,000.00 | 0.00 | 1,865,630,000.00 | 3,350,000.00 | 299,260,000.00 | 123,770,000.00 | 344,770,000.00 | 327,690,000.00 | 17,080,000.00 | 21,590,000.00 | 9,320,000.00 | 42,950,000.00 | -250,000.00 | 43,200,000.00 | 1,020,620,000.00 | 1,015,580,000.00 | 5,040,000.00 | 0.00 | 5,040,000.00 |
| 2022-03-31T00:00:00 | annual | 10,000,175.00 | 10,000,175.00 | 0.00 | 44,050,000.00 | 2,003,840,000.00 | 2,032,750,000.00 | 1,939,550,000.00 | 2,003,840,000.00 | 43,290,000.00 | 2,031,990,000.00 | 2,031,990,000.00 | 2,031,990,000.00 | 2,031,990,000.00 | 1,931,980,000.00 | 957,150,000.00 | 987,790,000.00 | 100,000,000.00 | 100,000,000.00 | 159,310,000.00 | 36,930,000.00 | -10,000.00 | 0.00 | 32,810,000.00 | 32,810,000.00 | 0.00 | 4,130,000.00 | 122,380,000.00 | 20,820,000.00 | 11,240,000.00 | 10,480,000.00 | 760,000.00 | 0.00 | 1,690,000.00 | 79,250,000.00 | 11,390,000.00 | 70,000.00 | 20,580,000.00 | 47,210,000.00 | 2,191,300,000.00 | 129,370,000.00 | 0.00 | 1,010,000.00 | 22,240,000.00 | 22,240,000.00 | 28,150,000.00 | 28,150,000.00 | 77,970,000.00 | -16,030,000.00 | 94,000,000.00 | 0.00 | 7,250,000.00 | 36,360,000.00 | 50,390,000.00 | 0.00 | 2,061,930,000.00 | 7,110,000.00 | 248,210,000.00 | 151,400,000.00 | 631,770,000.00 | 631,770,000.00 | 0.00 | 67,400,000.00 | 0.00 | 28,940,000.00 | 0.00 | 28,940,000.00 | 927,100,000.00 | 844,610,000.00 | 82,490,000.00 | 80,000,000.00 | 2,490,000.00 |
| 2021-03-31T00:00:00 | annual | 10,000,175.00 | 10,000,175.00 | 0.00 | 38,850,000.00 | 1,627,970,000.00 | 1,640,970,000.00 | 1,622,530,000.00 | 1,627,970,000.00 | 28,870,000.00 | 1,630,990,000.00 | 1,638,780,000.00 | 1,630,990,000.00 | 1,630,990,000.00 | 1,530,980,000.00 | 556,140,000.00 | 987,790,000.00 | 100,000,000.00 | 100,000,000.00 | 226,530,000.00 | 37,860,000.00 | -10,000.00 | 0.00 | 33,360,000.00 | 25,570,000.00 | 7,790,000.00 | 4,510,000.00 | 188,670,000.00 | 38,500,000.00 | 5,490,000.00 | 3,300,000.00 | 2,190,000.00 | 0.00 | 700,000.00 | 139,580,000.00 | 7,750,000.00 | 0.00 | 44,390,000.00 | 87,440,000.00 | 1,857,520,000.00 | 46,320,000.00 | 0.00 | 5,520,000.00 | 0.00 | 0.00 | 3,020,000.00 | 3,020,000.00 | 36,830,000.00 | -4,990,000.00 | 41,820,000.00 | 0.00 | 36,830,000.00 | 9,570,000.00 | 32,250,000.00 | 0.00 | 1,811,200,000.00 | 1,850,000.00 | 0.00 | 121,540,000.00 | 367,760,000.00 | 367,760,000.00 | 0.00 | 50,890,000.00 | 0.00 | 2,240,000.00 | -560,000.00 | 2,800,000.00 | 1,266,920,000.00 | 1,094,500,000.00 | 172,420,000.00 | 166,000,000.00 | 6,420,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 90,750,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10,000.00 | 1,010,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 80,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: NURECA Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Interest Paid Cff | Cash Dividends Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Intangibles Purchase And Sale | Purchase Of Intangibles | Net PPE Purchase And Sale | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -37,980,000.00 | -290,000.00 | 4,300,000.00 | 0.00 | -10,860,000.00 | 140,620,000.00 | 0.00 | 5,040,000.00 | -30,000.00 | 135,610,000.00 | -13,030,000.00 | -14,730,000.00 | 0.00 | 0.00 | 0.00 | 4,010,000.00 | 0.00 | 0.00 | 4,010,000.00 | -290,000.00 | 4,300,000.00 | 175,760,000.00 | 10,000.00 | 96,940,000.00 | 89,670,000.00 | 2,105,190,000.00 | -2,015,520,000.00 | 0.00 | 0.00 | -10,860,000.00 | -10,860,000.00 | -27,120,000.00 | 12,490,000.00 | 53,430,000.00 | 810,000.00 | -13,450,000.00 | 1,850,000.00 | 36,260,000.00 | 27,050,000.00 | -33,650,000.00 | 1,120,000.00 | 23,620,000.00 | 0.00 | 23,620,000.00 | -58,680,000.00 | -10,000.00 | -25,440,000.00 |
| 2023-03-31T00:00:00 | annual | 98,310,000.00 | 0.00 | 60,000.00 | 0.00 | -3,960,000.00 | 5,040,000.00 | 0.00 | 82,490,000.00 | -90,000.00 | -77,360,000.00 | -15,070,000.00 | -11,870,000.00 | 0.00 | 0.00 | 0.00 | 60,000.00 | 60,000.00 | 60,000.00 | 0.00 | 0.00 | 0.00 | -164,560,000.00 | 0.00 | 12,230,000.00 | -172,830,000.00 | 251,980,000.00 | -424,810,000.00 | 0.00 | 0.00 | -3,960,000.00 | -3,960,000.00 | 102,270,000.00 | -41,470,000.00 | 285,940,000.00 | -18,800,000.00 | 26,140,000.00 | 1,770,000.00 | 287,000,000.00 | -13,760,000.00 | -37,690,000.00 | 3,500,000.00 | 23,880,000.00 | 0.00 | 23,880,000.00 | -24,440,000.00 | -30,000.00 | -107,420,000.00 |
| 2022-03-31T00:00:00 | annual | -46,000,000.00 | -7,790,000.00 | 0.00 | 0.00 | -59,990,000.00 | 82,490,000.00 | 0.00 | 172,420,000.00 | -10,000.00 | -89,920,000.00 | -73,020,000.00 | -4,340,000.00 | -49,930,000.00 | 0.00 | 0.00 | -9,220,000.00 | -1,430,000.00 | 0.00 | -7,790,000.00 | -7,790,000.00 | 0.00 | -30,890,000.00 | 0.00 | 40,410,000.00 | -11,310,000.00 | 343,900,000.00 | -355,210,000.00 | -25,950,000.00 | -25,950,000.00 | -34,040,000.00 | -34,040,000.00 | 13,990,000.00 | -179,510,000.00 | -378,980,000.00 | -9,040,000.00 | -42,710,000.00 | -39,590,000.00 | -264,010,000.00 | -26,140,000.00 | -44,990,000.00 | 0.00 | 14,820,000.00 | 820,000.00 | 14,820,000.00 | -6,510,000.00 | -650,000.00 | 609,810,000.00 |
| 2021-03-31T00:00:00 | annual | 341,400,000.00 | -82,940,000.00 | 47,360,000.00 | 1,050,000,000.00 | -7,270,000.00 | 172,420,000.00 | 0.00 | 740,000.00 | 20,000.00 | 171,660,000.00 | 923,390,000.00 | -8,260,000.00 | 0.00 | 1,050,000,000.00 | 1,050,000,000.00 | -81,490,000.00 | 1,450,000.00 | 0.00 | -82,940,000.00 | -82,940,000.00 | 47,360,000.00 | -1,100,400,000.00 | 0.00 | 1,370,000.00 | -1,094,500,000.00 | 0.00 | -1,094,500,000.00 | -3,020,000.00 | -3,020,000.00 | -4,250,000.00 | -4,250,000.00 | 348,670,000.00 | -150,660,000.00 | -125,090,000.00 | 42,360,000.00 | -125,660,000.00 | 30,730,000.00 | -203,500,000.00 | 126,730,000.00 | -1,540,000.00 | 0.00 | 4,220,000.00 | 0.00 | 4,220,000.00 | 0.00 | -1,600,000.00 | 623,330,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 98,990,000.00 | 0.00 | 0.00 | 0.00 | 100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98,990,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: NURECA Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 1.59 | 0.00 | -5.25 | 5.38 | 5.38 | -1.79 | 2.36 | 60.62 | 0.14 | -2.23 | 3.40 | 0.32 | 3.89 | -5.59 | -1.79 | 104.03 | 0.85 | 1.00 | 1.00 | 0.00 | 0.00 | -1.79 | -1.79 | 0.00 | -1.79 | -1.79 | -1.79 | -0.75 | -2.54 | 0.26 | -0.47 | 0.47 | 3.40 | 0.17 | 0.32 | 3.89 | -12.10 | 43.42 | 15.60 | 2.36 | 0.32 | 2.05 | 12.40 | 10.19 | 2.21 | 0.85 | 31.31 | 60.62 | 91.93 | 91.93 |
| 2023-03-31T00:00:00 | annual | 0.51 | 0.00 | -10.21 | 2.19 | 2.19 | -8.25 | 2.39 | 75.53 | -8.02 | -10.41 | 3.77 | 0.34 | 4.22 | -9.93 | -8.25 | 128.47 | 1.02 | 1.00 | 1.00 | 0.00 | 0.00 | -8.25 | -8.25 | 0.00 | -8.25 | -8.25 | -8.25 | -2.49 | -10.74 | 0.26 | -0.26 | 0.26 | 3.77 | 0.11 | 0.34 | 4.22 | -17.14 | 52.93 | 18.88 | 2.39 | 0.29 | 2.10 | 14.59 | 11.16 | 3.43 | 1.02 | 35.79 | 75.53 | 111.32 | 111.32 |
| 2022-03-31T00:00:00 | annual | -0.03 | 0.00 | 63.03 | -0.13 | -0.13 | 44.96 | 1.48 | 132.62 | 62.90 | 61.42 | 4.50 | 0.44 | 5.24 | 45.05 | 44.96 | 200.74 | 0.64 | 1.00 | 1.00 | 0.00 | 0.00 | 44.96 | 44.96 | 0.00 | 44.96 | 44.96 | 44.96 | 16.02 | 60.98 | 0.25 | -0.78 | 0.78 | 4.50 | 0.31 | 0.44 | 5.24 | 54.81 | 68.12 | 28.96 | 1.48 | 0.08 | 1.40 | 27.12 | 21.91 | 5.22 | 0.64 | 122.92 | 132.62 | 255.55 | 255.55 |
| 2021-03-31T00:00:00 | annual | -0.28 | 0.00 | 65.33 | -1.09 | -1.09 | 46.37 | 0.42 | 99.48 | 64.23 | 63.81 | 0.15 | 1.48 | 1.76 | 47.19 | 46.37 | 151.24 | 0.22 | 0.75 | 0.75 | 0.00 | 0.00 | 46.37 | 46.37 | 0.00 | 46.37 | 46.37 | 46.37 | 15.96 | 62.33 | 0.10 | -1.09 | 1.09 | 0.15 | 0.13 | 1.48 | 1.76 | 62.21 | 51.76 | 29.96 | 0.42 | 0.00 | 0.42 | 16.58 | 15.73 | 0.86 | 0.22 | 113.97 | 99.48 | 213.45 | 213.45 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
-2.8
P/E
N/A
P/B
1.4534733
Dividend Yield
N/A
Market Cap
281.26 Cr.
Face Value
193.502
Book Value
193.502
ROE
-3.09%
EBITDA Growth
-14.94 Cr.
Debt/Equity
2.73
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of nureca?
The market capitalization of Nureca Limited is ₹281 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Nureca Limited?
The PE and PB ratios of Nureca Limited are Not Available and 1.4534733 respectively as of 05 Feb 2025.
What is the 52 Week High of Nureca Limited?
The 52-week high of Nureca Limited is ₹468.8 as of 05 Feb 2025.
What is the 52 Week Low of Nureca Limited?
The 52-week low of Nureca Limited is ₹240 as of 05 Feb 2025.
What are the earnings per share (EPS) for Nureca Limited?
The Earnings Per Share (EPS) of Nureca Limited is ₹-2.8 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Nureca Limited?
The Return on Equity (ROE) of Nureca Limited is -3.09% as per the most recent financial year data. Explore more on Fincept.